The Future of Cannabis

Cultivation Today

Request Information
Pure Science, Behind

Cannabinoids

Request Information
Kingdom In The

Sky

Request Information
Best In Class Products

Oils, Flower & Medication

Request Information

We are CGI

The company has a clear philosophy of driving its strategy and direction for the global opportunity for well-produced, branded, high quality, safe and effective medicinal and wellbeing products to effect real change in people’s lives. Our interlectual capital is creating a portfolio of related IP assets that meet clear commercial needs which offer our shareholders best-in-class returns.

Cannabinoid Industry Revolution

CGI PLC’s long-term aim is to develop Intellectual Property that can be licensed out to Pharmaceutical companies capable of bringing revolutionary cannabis-based drugs to market. We are building a diversified portfolio of cannabis-focused IP assets across brands, products, stains, and medical & process patents.

Impact Investing Ecosystem

Drawing on the specialist expertise, skills and proven corporate governance of the Board of Directors and global network of partnerships, CGI PLC is well placed to begin generating revenue in early 2020. We perform our research in partnership with specialist third parties such as third party labs, universities, hospitals, and where possible governments.

Who We Are

Canna Global Investments PLC (CGI PLC) is an agricultural biotechnology, investment and brands company with an extreme Impact Investing Ecosystem ethos. We focus on researching, developing, investing in and licensing sustainable medical cannabis and hemp products and their derived intellectual property. Our clients will have the confidence in knowing that our products will be free of harmful chemicals, metals, bacterial pathogens and microbiological contaminants. CGI PLC has a management team with deep expertise across R&D, product development, cannabis investing verticals, technology, sales and finance. Our ultimate vision is to create material shareholder value while advancing cannabanoid research & development or cheaper sustainable drugs.

Aims & Objectives

⬢

To be one of the World’s largest licensed producers of cannabis seed, medicinal extracts, and related products

⬢

To be one of the World's leading exporters of cannabis flower and its derived extracts into regulated global markets

⬢

To build successful commercial cultivation facilities and recognisable brands in a rapidly growing industry

LEADERSHIP TEAM

Geoffrey Asante

Executive Director

CGI

Ranjiv Goonawardena

Executive Director

CGI

Eduard Claihnet

Executive Director

CGI

NEWS & VLOGS

News

Promising Research – Cannabis Potentially Blocks COVID-19

Canna Global Investments Plc. has identified promising research with preliminary evidence that cannabis can potentially block the COVID-19 infection.

10/2/2020 11:13:56 PM

News

Medical cannabis product approved for epilepsy

The EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy.

9/24/2019 4:53:41 AM

Medical marijuana: Fastest growing industry in USA with $7 out of $10 spent on it.

Cannabis Europa: Focus on entry to the UK cannabis market though Africa.

CGI PLC is creating a portfolio of cannabis and hemp-related Intellectual Property assets that meet clear commercial needs which offer our shareholders best-in-class returns. CGI’s long term strategy is to be the global leader in the production of medical, recreational cannabinoid extracts, oils, nutraceuticals, and pharmaceuticals with a solid set of highly developed IP assets. These assets will be licensed to companies capable of delivering our revolutionary cannabis based products to the global market place.

Quick Links

Contact Us

Address:
Devonshire House, 1st Floor, 1 Mayfair Place,
London, W1J 8AJ, United Kingdom

Email: info@cgiplc.co.uk